In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents

Olorofim is a novel antifungal drug that belongs to the orotomide drug class which inhibits fungal dihydroorotate dehydrogenase (DHODH), thus halting pyrimidine biosynthesis and ultimately DNA synthesis, cell growth and division. It is being developed at a time when many invasive fungal infections e...

Full description

Bibliographic Details
Main Authors: Ourania Georgacopoulos, Natalie S. Nunnally, Eric M. Ransom, Derek Law, Mike Birch, Shawn R. Lockhart, Elizabeth L. Berkow
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Journal of Fungi
Subjects:
Online Access:https://www.mdpi.com/2309-608X/7/5/378
id doaj-356ca938388c4e69a7c33add6501103f
record_format Article
spelling doaj-356ca938388c4e69a7c33add6501103f2021-05-31T23:45:27ZengMDPI AGJournal of Fungi2309-608X2021-05-01737837810.3390/jof7050378In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal AgentsOurania Georgacopoulos0Natalie S. Nunnally1Eric M. Ransom2Derek Law3Mike Birch4Shawn R. Lockhart5Elizabeth L. Berkow6Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USAMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USAAssociation of Public Health Laboratories, Silver Springs, MD 20910, USAF2G Ltd., Manchester M30 0LX, UKF2G Ltd., Manchester M30 0LX, UKMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USAMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USAOlorofim is a novel antifungal drug that belongs to the orotomide drug class which inhibits fungal dihydroorotate dehydrogenase (DHODH), thus halting pyrimidine biosynthesis and ultimately DNA synthesis, cell growth and division. It is being developed at a time when many invasive fungal infections exhibit antifungal resistance or have limited treatment options. The goal of this study was to evaluate the in vitro effectiveness of olorofim against a large collection of recently isolated, clinically relevant American mold isolates. In vitro antifungal activity was determined for 246 azole-susceptible <i>Aspergillus fumigatus</i> isolates, five <i>A. fumigatus</i> with TR<sub>34</sub>/L98H-mediated resistance, 19 <i>Rhizopus</i> species isolates, 21 <i>Fusarium</i> species isolates, and one isolate each of six other species of molds. Olorofim minimum inhibitory concentrations (MICs) were compared to antifungal susceptibility testing profiles for amphotericin B, anidulafungin, caspofungin, isavuconazole, itraconazole, micafungin, posaconazole, and voriconazole. Olorofim MICs were significantly lower than those of the echinocandin and azole drug classes and amphotericin B. <i>A. fumigatus</i> wild type and resistant isolates shared the same MIC50 = 0.008 μg/mL. In non-<i>Aspergillus</i> susceptible isolates (MIC ≤ 2 μg/mL), the geometric mean (GM) MIC to olorofim was 0.54 μg/mL with a range of 0.015–2 μg/mL. Olorofim had no antifungal activity (MIC ≥ 2 μg/mL) against 10% of the collection (31 in 297), including some isolates from <i>Rhizopus</i> spp. and <i>Fusarium</i> spp. Olorofim showed promising activity against <i>A. fumigatus</i> and other molds regardless of acquired azole resistance.https://www.mdpi.com/2309-608X/7/5/378olorofimF901318filamentous fungiantifungal agents<i>Aspergillus fumigatus</i><i>Fusarium</i> spp.
collection DOAJ
language English
format Article
sources DOAJ
author Ourania Georgacopoulos
Natalie S. Nunnally
Eric M. Ransom
Derek Law
Mike Birch
Shawn R. Lockhart
Elizabeth L. Berkow
spellingShingle Ourania Georgacopoulos
Natalie S. Nunnally
Eric M. Ransom
Derek Law
Mike Birch
Shawn R. Lockhart
Elizabeth L. Berkow
In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents
Journal of Fungi
olorofim
F901318
filamentous fungi
antifungal agents
<i>Aspergillus fumigatus</i>
<i>Fusarium</i> spp.
author_facet Ourania Georgacopoulos
Natalie S. Nunnally
Eric M. Ransom
Derek Law
Mike Birch
Shawn R. Lockhart
Elizabeth L. Berkow
author_sort Ourania Georgacopoulos
title In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents
title_short In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents
title_full In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents
title_fullStr In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents
title_full_unstemmed In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents
title_sort in vitro activity of novel antifungal olorofim against filamentous fungi and comparison to eight other antifungal agents
publisher MDPI AG
series Journal of Fungi
issn 2309-608X
publishDate 2021-05-01
description Olorofim is a novel antifungal drug that belongs to the orotomide drug class which inhibits fungal dihydroorotate dehydrogenase (DHODH), thus halting pyrimidine biosynthesis and ultimately DNA synthesis, cell growth and division. It is being developed at a time when many invasive fungal infections exhibit antifungal resistance or have limited treatment options. The goal of this study was to evaluate the in vitro effectiveness of olorofim against a large collection of recently isolated, clinically relevant American mold isolates. In vitro antifungal activity was determined for 246 azole-susceptible <i>Aspergillus fumigatus</i> isolates, five <i>A. fumigatus</i> with TR<sub>34</sub>/L98H-mediated resistance, 19 <i>Rhizopus</i> species isolates, 21 <i>Fusarium</i> species isolates, and one isolate each of six other species of molds. Olorofim minimum inhibitory concentrations (MICs) were compared to antifungal susceptibility testing profiles for amphotericin B, anidulafungin, caspofungin, isavuconazole, itraconazole, micafungin, posaconazole, and voriconazole. Olorofim MICs were significantly lower than those of the echinocandin and azole drug classes and amphotericin B. <i>A. fumigatus</i> wild type and resistant isolates shared the same MIC50 = 0.008 μg/mL. In non-<i>Aspergillus</i> susceptible isolates (MIC ≤ 2 μg/mL), the geometric mean (GM) MIC to olorofim was 0.54 μg/mL with a range of 0.015–2 μg/mL. Olorofim had no antifungal activity (MIC ≥ 2 μg/mL) against 10% of the collection (31 in 297), including some isolates from <i>Rhizopus</i> spp. and <i>Fusarium</i> spp. Olorofim showed promising activity against <i>A. fumigatus</i> and other molds regardless of acquired azole resistance.
topic olorofim
F901318
filamentous fungi
antifungal agents
<i>Aspergillus fumigatus</i>
<i>Fusarium</i> spp.
url https://www.mdpi.com/2309-608X/7/5/378
work_keys_str_mv AT ouraniageorgacopoulos invitroactivityofnovelantifungalolorofimagainstfilamentousfungiandcomparisontoeightotherantifungalagents
AT nataliesnunnally invitroactivityofnovelantifungalolorofimagainstfilamentousfungiandcomparisontoeightotherantifungalagents
AT ericmransom invitroactivityofnovelantifungalolorofimagainstfilamentousfungiandcomparisontoeightotherantifungalagents
AT dereklaw invitroactivityofnovelantifungalolorofimagainstfilamentousfungiandcomparisontoeightotherantifungalagents
AT mikebirch invitroactivityofnovelantifungalolorofimagainstfilamentousfungiandcomparisontoeightotherantifungalagents
AT shawnrlockhart invitroactivityofnovelantifungalolorofimagainstfilamentousfungiandcomparisontoeightotherantifungalagents
AT elizabethlberkow invitroactivityofnovelantifungalolorofimagainstfilamentousfungiandcomparisontoeightotherantifungalagents
_version_ 1721416702646812672